PRODUCT DETAIL

Mytolente 90 mg injekčný roztok v naplnenej injekčnej striekačke

Code

7330D

MA number

56/0108/21-S

Product Form:

sol iru 3(3x1)x0,5 ml/90 mg (striek.inj.napl.PP+ihla-multibal.)

MA Status:

R - Valid Marketing Authorisation

Type of procedure:

Decentralised

Therapeutic Class:

56 - HORMONA (LIEČIVA S HORMONÁLNOU AKTIVITOU)

ATC:

H	SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H01	PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES
H01C	HYPOTHALAMIC HORMONES
H01CB	Antigrowth hormone
H01CB03	Lanreotide

Shelf life:

Container:

pre-filled syringe PP

Route of admin.:

Subcutaneous use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	06.05.2021
Validity:	06.05.2026
SPC:	SPC_Mytolente 60 mg 90 mg 120 mg sol iru_04 2021.pdf
PIL:	PIL_Mytolente_08_2023.pdf
Safety feature	Yes
Data update:	07.05.2021